谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

422P Nivolumab (NIV) Plus FOLFOXIRI/bevacizumab (BEV) As First-Line (1L) in Metastatic Colorectal Cancer (mcrc) RAS/BRAF Mutated (mut) Patients, Regardless of Microsatellite Status: Results of Phase II NIVACOR Trial (GOIRC-03-2018)

Angela Damato,Francesca Bergamo,Lorenzo Antonuzzo, G. Nasti,Filippo Pietrantonio,Giuseppe Tonini,Evaristo Maiello,Roberto Bordonaro, D. Bilancia,Alessandra Romagnani,Francesco Iachetta,Mario Larocca,Giuseppe Maglietta,Nicola Normanno,Carmine Pinto

Annals of oncology（2022）

引用 0|浏览1
暂无评分
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要